PSUSA/00002047/202412

PSUSA/00001013/202411

PSUSA/00002257/202412

Human medicines European public assessment report (EPAR): Idacio, adalimumab, Date of authorisation: 02/04/2019, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Sugammadex Fresenius Kabi, sugammadex, Date of authorisation: 15/07/2022, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Epoetin Alfa Hexal, epoetin alfa, Date of authorisation: 27/08/2007, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Binocrit, epoetin alfa, Date of authorisation: 28/08/2007, Revision: 25, Status: Authorised

Antimicrobial Sales and Use (ASU) Platform: Release notes

Human medicines European public assessment report (EPAR): Abseamed, epoetin alfa, Date of authorisation: 27/08/2007, Date of refusal: 18/06/2009, Revision: 26, Status: Authorised

SPOR and XEVMPD status update webinar, Broadcast, from 9 April 2025, 10:00 (CEST) to 9 April 2025, 12:30 (CEST)